0001437749-19-017313.txt : 20190822 0001437749-19-017313.hdr.sgml : 20190822 20190822201139 ACCESSION NUMBER: 0001437749-19-017313 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190820 FILED AS OF DATE: 20190822 DATE AS OF CHANGE: 20190822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mathers James CENTRAL INDEX KEY: 0001676166 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 191046959 MAIL ADDRESS: STREET 1: C/O BIOLIFE SOLUTIONS STREET 2: 3303 MONTE VILLA PARKWAY, SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 rdgdoc.xml FORM 4 X0306 4 2019-08-20 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001676166 Mathers James C/O BIOLIFE SOLUTIONS, INC. 3303 MONTE VILLA PARKWAY, SUITE 310 BOTHELL WA 98021 1 Vice President, Global Sales Common Stock 2019-08-20 4 M 0 2500 1.64 A 19884 D Common Stock 2019-08-20 4 S 0 2500 20.06 D 17384 D Common Stock 2019-08-21 4 M 0 2500 1.64 A 19884 D Common Stock 2019-08-21 4 S 0 2500 20.52 D 17384 D Common Stock 2019-08-22 4 M 0 2500 1.64 A 19884 D Common Stock 2019-08-22 4 S 0 2500 20.77 D 17384 D Employee Stock Option 1.64 2019-08-20 4 M 0 2500 0 D 2019-03-01 2021-12-20 Common Stock 2500 89613 D Employee Stock Option 1.64 2019-08-21 4 M 0 2500 0 D 2019-03-01 2021-12-20 Common Stock 2500 87113 D Employee Stock Option 1.64 2019-08-22 4 M 0 2500 0 D 2019-03-01 2021-12-20 Common Stock 2500 84613 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. /s/ James Mathers 2019-08-22